POST-ERCP PANCREATITIS
Clinical trials for POST-ERCP PANCREATITIS explained in plain language.
Never miss a new study
Get alerted when new POST-ERCP PANCREATITIS trials appear
Sign up with your email to follow new studies for POST-ERCP PANCREATITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a double dose of a simple suppository prevent a serious complication?
Prevention Not yet recruitingThis study compares two doses (100 mg vs 200 mg) of rectal indomethacin to prevent pancreatitis after ERCP, a procedure to treat bile duct problems. About 1,036 high-risk adults will be randomly assigned to receive either the standard or a higher dose right after the procedure. T…
Matched conditions: POST-ERCP PANCREATITIS
Phase: PHASE4 • Sponsor: The First Affiliated Hospital of Anhui Medical University • Aim: Prevention
Last updated May 18, 2026 12:12 UTC
-
Stent timing trial aims to cut pancreatitis complications
Knowledge-focused Not yet recruitingThis study looks at the best time to remove a small plastic tube (stent) placed in the pancreas after a common bile duct procedure called ERCP. The stent is meant to prevent pancreatitis, but keeping it too long or removing it can cause side effects. About 358 adults who need thi…
Matched conditions: POST-ERCP PANCREATITIS
Phase: NA • Sponsor: Johann Wolfgang Goethe University Hospital • Aim: Knowledge-focused
Last updated May 20, 2026 11:54 UTC